Skip to content

Clinical trials

Phase 3 Breast Neoplasms trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 3 Status: Unknown status Clear all

144 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20022
20031
20045
20055
20066
20077
200811
20097
20106
20115
20125
20134
20147
20159
201612
20177
20185
20196
20202
20215
20224
20235

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status144

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University9
Chinese Academy of Medical Sciences4
Institute of Cancer Research, United Kingdom4
Peking Union Medical College Hospital4
Cambridge University Hospitals NHS Foundation Trust3
Consorzio Oncotech3
The Netherlands Cancer Institute3
Association Européenne de Recherche en Oncologie2
Canadian Breast Cancer Research Alliance2
Gruppo Italiano Mammella (GIM)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms144
Neoplasm Metastasis7
Breast Neoplasms, Male4
Cardiotoxicity3
Inflammatory Breast Neoplasms3
Triple Negative Breast Neoplasms3
Brain Neoplasms2
Breast Diseases2
Colonic Neoplasms2
Colorectal Neoplasms2

Trials

Showing 1 to 25 of 144. Each trial links to its page on Pharma Observatory.

44 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.